Nanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery
نویسندگان
چکیده
منابع مشابه
Chitosan-based Nanoparticles in Mucosal Vaccine Delivery
Most infectious diseases are caused by pathogenic infiltrations from the mucosal tract. Nowadays, the use of vaccines has been widely investigated for the prevention of different infectious diseases, infertility, immune disorders, malignancies, and allergies. Broad-spectrum adjuvant substances have been studied for immune system stimulation with a greater efficiency against specific antigens. V...
متن کاملNanoparticle Technology for Drug Delivery
La tecnología de nanopartículas se espera que revolucione la manera en que se lleva a cabo la administración de fármacos. Las tecnologías de nanopartículas tienen la capacidad de mejorar la eficacia de los medicamentos, reducir al mínimo los efectos secundarios, y proporcionar una entrega específica, sólo para nombrar algunos. Con el fin de aprovechar las aplicaciones y ventajas de las nanopart...
متن کاملNanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
Development of nano-sized carriers including nanoparticles, nanoemulsions or liposomes holds great potential for advanced delivery systems for cancer immunotherapy, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to specific target sites. Successful development of nanotechnology based platform in the field of immunotherapy will allo...
متن کاملNovel Vaccine Delivery Technology
Infections of the respiratory and GI tracts are among the most common diseases of piglets worldwide and cause substantial economic loss to swine producers. Effective immunity to these infections needs a specific response at the surface of the tract (Bozic et al., 2002). However vaccine formulation and delivery to these surfaces remains a major challenge. Recent evidence of this type of immune r...
متن کاملHelicobacter pylori vaccine: mucosal adjuvant & delivery systems.
Vaccination, especially mucosal vaccination, is considered to be effective in the management of Helicobacter pylori infections. However, most antigens alone cannot induce immune responses when administered mucosally and need to be co-administered with adjuvants or delivery systems. The current research on the mucosal adjuvant and delivery systems of vaccine against H. pylori, including advantag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: KONA Powder and Particle Journal
سال: 2020
ISSN: 0288-4534,2187-5537
DOI: 10.14356/kona.2020013